Specifications

“My laboratory has published two recent manuscripts reporting the use of FLAG-K63 and FLAG K48 TUBE reagents. We used these reagents to study the ubiquitination of the nonstructural 2 transmembrane protein of hepatitis C virus (HCV) by the cellular E3 ligase MARCH8. By being quite selective and easy to handle, these reagents helped us characterize the specific ubiquitin modification.”

Dr. Shirit Einav, Associate Professor, Department of Microbiology and Immunology, Stanford University of Medicine

FLAG® Anti-K63 TUBE is an ideal reagent for efficient isolation and enrichment of K63-polyubiquitinated proteins from cell & tissue extracts or in vitro synthesized mixtures. Based on a peptide engineered by Sims et al., it consists of multiple ubiquitin interaction motifs (UIMs) joined by a rigid, helical linker that spaces the UIMs for selective binding to extended K63-linked polyubiquitin chains. The result is a peptide the exhibits high affinity binding to K63-linked polyubiquitin together with 1000 to 10,000-fold selectivity over K48- and K11- linkages. Expression of this peptide in vitro inhibits K63-linked polyubiquitin-dependent processes and protects K63-linked polyubiquitin chains from degradation. Combining this peptide with a FLAG epitope tag generates, for the first time, a powerful affinity reagent suitable for isolation, purification and characterization of proteins modified by K63-linked polyubiquitin. Flag K63-TUBE 1 allows isolation of K63-linked polyubiquitin without the need for overexpression of ubiquitin mutants, tagged ubiquitins or the inclusion of DUB inhibitors any of which could alter cellular physiology. Isolated ubiquitinated proteins can be characterized by Western blot, mass spec or further biochemical analysis. (FLAG is a registered trademark of Sigma-Aldrich Corporation LLC).

This product is protected by one or more US or Foreign patents. Please read the Limited Use Label License to learn more. By purchasing this product, the purchaser agrees to comply with these terms.

Info

LifeSensors成立于1996年，位于美国宾夕法尼亚州费城，是一家为药物发现与研究提供方法和可行性技术方法的生物技术公司。公司致力于为泛素和泛素蛋白酶体通路研究领域提供高品质的抗体、酶、蛋白质等试剂和试剂盒，产品最全、最新，是泛素研究者的最佳选择。其原核和真核蛋白表达系统SUMOpro和SUMOstar已被世界范围内的学术、政府研究机构和制药、生物技术公司广泛应用。通过提供创新的研究工具，LifeSensors已成为泛素和泛素样蛋白途径的领导者。